Literature DB >> 12787303

Early acquisition of serum and saliva antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins by infants living in an endemic area.

Cristiane Barros Carbonare1, Solange Barros Carbonare, Magda Maria Sales Carneiro-Sampaio.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is the most common etiological agent of acute diarrhea among infants living in poor social conditions in Brazil and other developing countries. This infection is rare in breast-fed infants, as well as in children older than 2 years. Over the past few years, our group has attempted to identify antibodies to EPEC virulence proteins in human milk and to establish the in vitro protective role of these antibodies. In the present study, we report the identification of antibodies to EPEC virulence proteins in sera and saliva from children of different ages, living in slums in the city of São Paulo, Brazil. Using EPEC and bacterial constructs (pET) for immunoblotting (IB) analysis, antibodies reacting to the main adhesins (intimin, bundle-forming pilli) and cell-signaling proteins (EPEC secreted proteins - Esp A, Esp B) were detected in sera from adults and children older than 1 year. Almost all children older than 1 year presented recognition patterns similar to those of adults in IB assays for serum IgG and secretory IgA antibodies, using EPEC outer membrane and other antigenic preparations. As previously observed for human milk, all samples from adults and older children recognized the 94 kDa molecular weight adhesin intimin strongly. In most children, previous EPEC symptomatic diarrhea could not be confirmed; however, almost all of them have presented one or more diarrhea episodes during their lifetime. These results suggest that reduction of EPEC infection frequency after 2 years of age may be associated with the development of anti-EPEC antibody repertoires.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787303     DOI: 10.1034/j.1399-3038.2003.00028.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

1.  Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn.

Authors:  Patricia Palmeira; Leonardo Yu Ito; Christina Arslanian; Magda Maria Sales Carneiro-Sampaio
Journal:  Eur J Pediatr       Date:  2006-10-21       Impact factor: 3.183

2.  Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.

Authors:  Carla Calderon Toledo; Ida Arvidsson; Diana Karpman
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

3.  Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.

Authors:  María Pilar Mejias; Gabriel Cabrera; Romina Jimena Fernández-Brando; Ariela Baschkier; Giselle Ghersi; Maria Jimena Abrey-Recalde; Elizabeth Miliwebsky; Roberto Meiss; Fernando Goldbaum; Vanesa Zylberman; Marta Rivas; Marina Sandra Palermo
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

4.  Colostrum from healthy Brazilian women inhibits adhesion and contains IgA antibodies reactive with Shiga toxin-producing Escherichia coli.

Authors:  Patricia Palmeira; Solange Barros Carbonare; José Araujo Amaral; Milene Tino-De-Franco; Magda Maria Sales Carneiro-Sampaio
Journal:  Eur J Pediatr       Date:  2004-11-10       Impact factor: 3.183

5.  Role of enteropathogenic Escherichia coli in paediatric diarrhoeas in South India.

Authors:  Gandham Pavani Tilak; Jyothi Lakshmi G Mudaliar
Journal:  Mater Sociomed       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.